Packaged Foods & Meats
Post Holdings Inc (POST)
BUY. 12-month probability-weighted target $86 (+15% vs spot). Gross Margin explains 45% of Monte Carlo outcome variance.
General Mills Inc (GIS)
HOLD. 12-month probability-weighted target $35 (+9% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.
Hormel Foods Corporation (HRL)
BUY. 12-month probability-weighted target $25 (+30% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.
Campbell’s Co (CPB)
HOLD. 12-month probability-weighted target $20 (+6% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.
Kraft Heinz Co (KHC)
HOLD. 12-month probability-weighted target $23 (+2% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.
Conagra Brands, Inc. (CAG)
HOLD. 12-month probability-weighted target $13 (-4% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.
Tyson Foods Inc (TSN)
HOLD. 12-month probability-weighted target $59 (+11% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.
McCormick & Company Incorporated (MKC)
HOLD. 12-month probability-weighted target $49 (+9% vs spot). Gross Margin explains 50% of Monte Carlo outcome variance.
Hershey Co (HSY)
HOLD. 12-month probability-weighted target $169 (+4% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.
Lamb Weston Holdings Inc (LW)
SELL. 12-month probability-weighted target $42 (-12% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.
Pilgrims Pride Corp (PPC)
HOLD. 12-month probability-weighted target $28 (-1% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.
The J. M. Smucker Company (SJM)
HOLD. 12-month probability-weighted target $110 (-8% vs spot). P/E Multiple explains 49% of Monte Carlo outcome variance.
Mondelez International Inc (MDLZ)
HOLD. 12-month probability-weighted target $58 (-4% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.
The Marzetti Company (MZTI)
Rating suspended since 2026-09-21 — valuation input under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.